Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Provention Bio

Request full access

Clinical stage biopharmaceutical dedicated to sourcing, developing and commercializing novel therapeutics

Lebanon, United StatesFounded 2016Biotech & Life Sciences

About Provention Bio

Provention Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. The company operates in the healthcare sector, specifically targeting autoimmune and inflammatory diseases. Provention Bio serves patients who suffer from chronic conditions such as Type 1 Diabetes (T1D), Crohn's Disease, and Systemic Lupus Erythematosus. The company's business model revolves around the research, development, and commercialization of its therapeutic candidates. Revenue is generated primarily through partnerships, licensing agreements, and eventual product sales upon regulatory approval. Provention Bio aims to reduce the high morbidity, mortality, and escalating costs associated with these diseases by intervening before they begin, reappear, or progress. The company is dedicated to transforming treatment paradigms into interception and prevention strategies, thereby improving the quality of life for millions of patients worldwide.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2018

Provention Bio in the Lebanon ecosystem

Live from Dealroom

The Provention Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Johnson & Johnson Innovation
  • JDRF T1D Fund
  • MDB Capital Group
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Lebanon HQ
Book a demo for the full country breakdown

Patents

Estimated portfolio value
$4M

20 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Provention Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.